Table 3.

End of Year 1 characteristics of participants with improved/unchanged outcomes (total responders) and deteriorated outcomes (total nonresponders) at the end of Year 2 as compared to the end of Year 1. Values are mean (SD) unless otherwise specified.

CharacteristicsResponders, n = 54Nonresponders, n = 105p
Age, yrs59 (9.6)61 (8.4)0.1784
Females, n (%)46 (85)81 (77)0.2310
University education, n (%)34 (63)50 (48)0.0664
Income above average, n (%)42 (78)70 (67)0.1694
Children at home, n (%)12 (22)12 (11)0.0718
Disease duration, yrs11 (8.3)13 (9.5)0.3003
Comorbidites, n (%)
  023 (43)46 (44)0.3686
  18 (15)24 (23)0.3686
  2 +23 (43)35 (33)0.3686
Current HEPA, n (%)49 (91)80 (76)0.0421
Maintained HEPA, n (%)27 (50)62 (59)0.2610
Health, VAS, 0–10019 (17.4)28 (23)0.0060
Pain, VAS, 0–10021 (17.4)25 (23)0.2235
Fatigue, VAS, 0–10029 (22.4)34 (25.7)0.2535
Quality of life, EQ-5D, 0–10078 (15.0)76 (18.9)0.3735
Activity limitation, HAQ-DI, 0–30.29 (0.39)0.30 (0.45)0.8572
Exercise self-efficacy, 6–6035 (11.2)33 (12.5)0.2571
Fear avoidance beliefs, 0–245 (4.2)5 (4.2)0.8521
Social support, 0–65
  Family30 (13.4)27 (13.3)0.2823
  Friends27 (12.7)22 (12.7)0.0707
OE longterm health = 1048 (89)80 (76)0.0556
OE RA symptoms = 1023 (43)46 (44)0.8834
VO2max, ml/kg/min31 (9.1)29 (7.5)0.2613
Timed standing, s16 (5.6)19 (7.1)0.0119
Grip strength max right, n240 (104.0)235 (118.3)0.7527
BMI, kg/m226 (5.0)27 (4.9)0.2293
Waist circumference, cm87 (14.2)91 (13.4)0.1328
Systolic blood pressure, mmHg132 (18.8)134 (17.0)0.5639
Diastolic blood pressure, mmHg81 (9.9)82 (8.6)0.4143
  • Alpha level set at 0.05 (shown in bold face). Health: general health perception; HEPA: health-enhancing physical activity; VAS: visual analog scale; HAQ-DI: Health Assessment Questionnaire–Disability Index; OE: outcome expectations; RA: rheumatoid arthritis; VO2max: maximal oxygen uptake; BMI: body mass index.